Evidence map›Paper›PMID 35981748›Full record

ArticleBMJ case reports2022

Recovery from AA amyloidosis-cardiomyopathy complexed with unicentric Castleman disease.

Kanako Imamura, Sunao Kojima, Takahisa Imamura, Kenichi Tsujita

Open access · greenAbstract readCase Reports
PubMed Full text at PMC Publisher
In one paragraph

Article in BMJ case reports, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
0.1field-weighted citation impact, top 57% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 2 citations in OpenAlex.

  1. Review
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 3 institutions in 1 country.

Kanako ImamuraDepartment of Laboratory Medicine, Kumamoto University Hospital, Kumamoto, Japan.
Sunao KojimaDepartment of Internal Medicine, Sakura-jyuji Yatsushiro Rehabilitation Hospital, Yatsushiro, Japan kojimas@kumamoto-u.ac.jp.ORCID http://orcid.org/0000-0002-1916-7252
Takahisa ImamuraDepartment of Life Science, Shokei University, Kumamoto, Japan.
Kenichi TsujitaDepartment of Cardiovascular Medicine, Graduate School of Medical Sciences, Kumamoto University, Kumamoto, Japan.
Kumamoto University · JPKumamoto University Hospital · JPShokei College · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

We report a case of cardiac amyloid A (AA) amyloidosis due to unicentric Castleman disease (UCD) in a patient whose cardiac function was restored 15 years after surgical resection of the mesenteric lymph node lesion. A man in his 40s had recurrent palpitations and fainting spells. ECG revealed

Indexed as

AmyloidosisCardiomyopathiesCastleman DiseaseC-Reactive ProteinHumansInterleukin-6MaleSerum Amyloid A ProteinC-Reactive ProteinInterleukin-6Serum Amyloid A ProteinArrhythmiasCardiovascular medicineHaematology (incl blood transfusion)Heart failureSurgery

Identifiers

PMID35981748
PMCPMC9394191
OpenAlexW4292212767

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.